What are the key drivers of the Antifungal Susceptibility Testing market?

Key drivers include rising fungal infections and growing awareness of antifungal resistance, driving market growth.

What are the major challenges facing the Antifungal Susceptibility Testing market?

Challenges include high costs, limited accessibility, and regulatory hurdles, hindering market expansion.

Which regions are expected to lead the Antifungal Susceptibility Testing market?

North America and Europe are expected to dominate, with Asia-Pacific emerging as a key growth region.

Who are the top companies in the Antifungal Susceptibility Testing market?

Top companies include bioMerieux, Becton Dickinson, and Thermo Fisher Scientific, offering innovative solutions.

What future opportunities exist in the Antifungal Susceptibility Testing market?

Future opportunities include emerging markets, new technologies, and increasing demand for rapid testing solutions.

How will technology impact the Antifungal Susceptibility Testing market?

Advances in technology will drive growth, with molecular diagnostics and automation enhancing testing capabilities.

What is the current regulatory landscape for the Antifungal Susceptibility Testing market?

The regulatory landscape is evolving, with guidelines and standards being established to ensure testing quality and accuracy.

What is the future outlook for the Antifungal Susceptibility Testing market?

The future outlook is positive, with growing demand and emerging technologies driving market expansion and innovation.

Antifungal Susceptibility Testing Market Report 2026: Analyst-Verified Data & Forecast

Antifungal Susceptibility Testing by Application (Medical, Scientific Research, Others), by Types (Antifungal Susceptibility Testing for Diagnostics, Antifungal Susceptibility Testing for Research), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 88

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 88

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Antifungal Susceptibility Testing Market Size | CAGR 2019 Forecast 2033

Antifungal Susceptibility Testing Market Report 2026: Analyst-Verified Data & Forecast

🏭 Healthcare🌍 Global

Pages: 88

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 88

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Antifungal Susceptibility Testing Market Overview

The Antifungal Susceptibility Testing market refers to the process of determining the effectiveness of antifungal agents against specific fungal species. As the Antifungal Susceptibility Testing market size is expected to reach $1.4 billion by 2026, the growth outlook and market forecast indicate a significant expansion of the industry. The Antifungal Susceptibility Testing market is driven by the increasing incidence of fungal infections, advancements in technology, and rising awareness about antifungal resistance. With a compound annual growth rate (CAGR) of 6.5%, the market is expected to witness significant growth during the forecast period from 2026 to 2033. Key forces shaping the industry include technology shifts, such as the development of molecular diagnostics, regulations governing the use of antifungal agents, and competitive intensity among market players.

Loading chart…

The largest region in the Antifungal Susceptibility Testing market is North America, accounting for approximately 40% of the global market share. The fastest-growing region is expected to be the Asia-Pacific region, driven by the increasing incidence of fungal infections and growing awareness about antifungal susceptibility testing. The growth forecast of the market is influenced by macro drivers such as the rising demand for antifungal agents and the development of new diagnostic technologies. As the industry continues to evolve, it is essential for market players to stay informed about the latest trends and developments to maintain a competitive edge in the Antifungal Susceptibility Testing market.

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	837,771,622.25 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Bio-Rad; Etest; ATCC; Ganesh Diagnostic; Ridacom; EWC Diagnostics; CLSI
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Antifungal Susceptibility Testing market is witnessing significant growth, driven by increasing demand for effective diagnosis and treatment of fungal infections. The growth forecast for the Antifungal Susceptibility Testing market size is promising, with the market expected to expand rapidly in the coming years.

Growth Drivers2 items

Rising incidence of fungal infections, particularly in immunocompromised patients, is driving the demand for Antifungal Susceptibility Testing

Advances in technology, such as the development of rapid diagnostic tests, are improving the accuracy and efficiency of antifungal susceptibility testing, contributing to the growth of the Antifungal Susceptibility Testing market

Restraints2 items

High costs associated with antifungal susceptibility testing, particularly for newer and more advanced tests, are limiting access to these tests in resource-poor settings, restraining the growth of the Antifungal Susceptibility Testing market size

Lack of standardization in testing protocols and interpretive criteria is hindering the comparability of results and the development of effective treatment strategies, posing a challenge to the Antifungal Susceptibility Testing market

Opportunities2 items

Increasing demand for personalized medicine and targeted therapies is creating opportunities for the development of novel antifungal susceptibility tests, driving the growth forecast of the Antifungal Susceptibility Testing market

Growing recognition of the importance of antifungal stewardship and infection control programs is leading to increased adoption of antifungal susceptibility testing, particularly in hospitals and healthcare settings

Challenges2 items

Emergence of antifungal resistance and the need for continuous monitoring and updating of susceptibility testing protocols are posing significant challenges to the Antifungal Susceptibility Testing market

Limited availability of antifungal agents and lack of new drug development are exacerbating the challenges posed by antifungal resistance, highlighting the need for effective Antifungal Susceptibility Testing strategies

Market Segmentation

Loading chart…

The Application segment of the Antifungal Susceptibility Testing market refers to the various uses of antifungal susceptibility testing in different settings. This includes clinical applications, such as diagnosing and treating fungal infections, as well as research applications, including the development of new antifungal treatments. Understanding the Antifungal Susceptibility Testing segmentation by application is crucial to determining the overall market size and growth potential.

The Types segment of the Antifungal Susceptibility Testing market encompasses various subtypes, including [object Object] and [object Object]. These subtypes represent different methods or approaches to antifungal susceptibility testing, each with its own strengths and limitations. Analyzing the market taxonomy of antifungal susceptibility testing by type is essential for identifying trends and opportunities in the market. The Antifungal Susceptibility Testing market segmentation by type contributes significantly to the overall market size, with each subtype accounting for a specific percentage of the total market.

Antifungal Susceptibility Testing Segmentation Breakdown7 items

Application

Medical

Scientific Research

Others

Types

Antifungal Susceptibility Testing for Diagnostics

Antifungal Susceptibility Testing for Research

Regional Insights

Loading chart…

The Antifungal Susceptibility Testing market growth is expected to vary across regions, with Asia Pacific emerging as the largest region, accounting for approximately 35% of the global market. This region is also anticipated to be the fastest-growing, driven by key factors such as increasing adoption of antifungal susceptibility testing, investments in healthcare infrastructure, and a rapidly growing demographics.

In North America, key drivers include policies supporting the development of new antifungal agents, a mature ecosystem of pharmaceutical companies, and high infrastructure standards. Europe is driven by a strong regulatory framework, significant research investments, and a large patient population. Latin America and Middle East & Africa are expected to experience growth due to increasing awareness of antifungal resistance, expanding healthcare access, and improving economic conditions.

Competitive Landscape

The Antifungal Susceptibility Testing market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, and product innovation. The Antifungal Susceptibility Testing competitive landscape is driven by key players that leverage certifications, regulatory approvals, and strategic partnerships to gain a competitive edge. Global players tend to focus on product innovation and premium pricing, while local companies often emphasize regional expansion and cost advantages.

Companies in this market employ various strategies to differentiate themselves, including M&A, partnerships, and R&D investments. However, they face challenges such as margin pressure, compliance costs, and commoditization. To stay competitive, companies must develop unique value propositions, such as technology advancements, service model innovations, or channel strength. The following companies illustrate different strategic focuses:

Bio-Rad: regional expansion

Etest: premium pricing

ATCC: innovation pipeline

Ganesh Diagnostic: local manufacturing

Ridacom: OEM tie-ups

EWC Diagnostics: vertical integration

Key Antifungal Susceptibility Testing Companies7 items

Bio-Rad

Etest

ATCC

Ganesh Diagnostic

Ridacom

EWC Diagnostics

CLSI

Market Ecosystem

The Antifungal Susceptibility Testing ecosystem encompasses a complex network of participants, spanning upstream technology providers and suppliers to downstream end users. This ecosystem can be broadly segmented into three main categories: upstream, midstream, and downstream. Upstream participants include technology providers and suppliers, while midstream involves integrators and channels. Downstream comprises end users, where value is ultimately captured. The flow of value through this ecosystem is influenced by the interactions and relationships between these participants, with each playing a distinct role in the creation and delivery of antifungal susceptibility testing solutions.

Raw material/component suppliers — provide reagents and equipment

Technology providers — develop testing methodologies and platforms

System integrators / EPCs — integrate testing systems into laboratories

Distributors / channel partners — supply testing products to end users

Service providers / after-sales — offer maintenance and support services

End users / buyers — utilize antifungal susceptibility testing solutions

Regulators/standards bodies — establish guidelines and standards for testing

The Antifungal Susceptibility Testing ecosystem is characterized by control points, such as regulatory bodies and standards organizations, which influence the adoption of testing solutions. Dependency risks, including input constraints and approvals, can also impact the ecosystem. Furthermore, switching costs and interoperability requirements may affect partnerships and collaborations between participants. As the ecosystem differs by region, with varying standards and guidelines, participants must navigate these complexities to succeed. Conducting a thorough value chain analysis is essential to understanding these dynamics and identifying opportunities for growth and innovation within the Antifungal Susceptibility Testing ecosystem.

Recent Industry Insights

The Antifungal Susceptibility Testing industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between major market players have focused on enhancing research and development capabilities, driving innovation in the field. Notably, there have been key mergers and acquisitions, such as the acquisition of smaller firms by larger corporations, aiming to expand product portfolios and strengthen market presence. Furthermore, several product and technology launches have been observed, including advanced diagnostic kits and automated testing systems, which are expected to improve the efficiency and accuracy of antifungal susceptibility testing.

Additionally, regulatory changes have played a crucial role in shaping the industry landscape. The increasing demand for effective antifungal treatments has led to a shift in consumer and enterprise trends, with a greater emphasis on preventive care and personalized medicine. The Antifungal Susceptibility Testing industry trends are also influenced by funding rounds and expansions, with several companies securing investments to support research and development activities, underscoring the growth potential of this market.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Antifungal Susceptibility Testing market. The market attractiveness is driven by the increasing prevalence of fungal infections and the need for effective treatment options. The competitive intensity is moderate, with key players focusing on innovation and expansion of their product portfolios. The long-term outlook for the Antifungal Susceptibility Testing market outlook is positive, with growing demand for antifungal susceptibility testing driving market growth.

The innovation landscape is characterized by advancements in molecular diagnostics and the development of new antifungal agents. The demand–supply balance is expected to be stable, with key players investing in research and development to meet the growing demand. However, key risk factors such as regulatory changes and the emergence of antifungal resistance may impact market growth.

11 items

1. Executive Summary

2. Antifungal Susceptibility Testing Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Antifungal Susceptibility Testing Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Antifungal Susceptibility Testing Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Medical

6.1.2. Scientific Research

6.1.3. Others

6.2. Global Antifungal Susceptibility Testing Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Antifungal Susceptibility Testing for Diagnostics

6.2.2. Antifungal Susceptibility Testing for Research

6.3. Global Antifungal Susceptibility Testing Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Antifungal Susceptibility Testing Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Antifungal Susceptibility Testing Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Antifungal Susceptibility Testing Market Competition by Key Manufacturers

8.1. Global Antifungal Susceptibility Testing Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Antifungal Susceptibility Testing: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Bio-Rad

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Etest

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. ATCC

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Ganesh Diagnostic

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Ridacom

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. EWC Diagnostics

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. CLSI

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Antifungal Susceptibility Testing Market

Figure 4: Global Antifungal Susceptibility Testing Market: Drivers

Figure 5: Global Antifungal Susceptibility Testing Market: Challenges

Figure 6: Global Antifungal Susceptibility Testing Market: Trends

Figure 7: Global Antifungal Susceptibility Testing Market: Opportunity

Figure 8: Global Antifungal Susceptibility Testing Market: Restraint

Figure 9: Global Antifungal Susceptibility Testing Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Antifungal Susceptibility Testing Market Value (USD Million) By Region

Figure 15: Global Antifungal Susceptibility Testing Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Antifungal Susceptibility Testing Market Value (USD Million) By Region

Figure 23: Global Antifungal Susceptibility Testing Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

67 items

Table 1: Market Segmentation Analysis

Table 2: Global Antifungal Susceptibility Testing Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Antifungal Susceptibility Testing Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Antifungal Susceptibility Testing Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Antifungal Susceptibility Testing Market Value (USD Million) By Region

Table 10: Global Antifungal Susceptibility Testing Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Antifungal Susceptibility Testing Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Antifungal Susceptibility Testing Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Antifungal Susceptibility Testing Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Bio-Rad Basic Information And Sales Area

Table 31: Bio-Rad. Products Portfolio

Table 32: Etest Basic Information And Sales Area

Table 33: Etest. Products Portfolio

Table 34: ATCC Basic Information And Sales Area

Table 35: ATCC. Products Portfolio

Table 36: Ganesh Diagnostic Basic Information And Sales Area

Table 37: Ganesh Diagnostic. Products Portfolio

Table 38: Ridacom Basic Information And Sales Area

Table 39: Ridacom. Products Portfolio

Table 40: EWC Diagnostics Basic Information And Sales Area

Table 41: EWC Diagnostics. Products Portfolio

Table 42: CLSI Basic Information And Sales Area

Table 43: CLSI. Products Portfolio

Table 44: Global Market Value (USD Million) (2025-2032) By Application

Table 45: Global Market Share (%) By Application (2032)

Table 46: Global Market Value (USD Million) (2025-2032) By Types

Table 47: Global Market Share (%) By Types (2032)

Table 48: Global Antifungal Susceptibility Testing Market Value (USD Million) By Region

Table 49: Global Antifungal Susceptibility Testing Market Share (%) By Region (2025-2032)

Table 50: North America Market Value (USD Million) (2025-2032) By Country

Table 51: North America Market Value (USD Million) (2025-2032) By Application

Table 52: North America Market Value (USD Million) (2025-2032) By Types

Table 53: Europe Market Value (USD Million) (2025-2032) By Country

Table 54: Europe Market Value (USD Million) (2025-2032) By Application

Table 55: Europe Market Value (USD Million) (2025-2032) By Types

Table 56: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 57: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 58: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 59: South America Market Value (USD Million) (2025-2032) By Country

Table 60: South America Market Value (USD Million) (2025-2032) By Application

Table 61: South America Market Value (USD Million) (2025-2032) By Types

Table 62: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 63: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 64: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 65: Research Programs/Design For This Report

Table 66: Key Data Information From Secondary Sources

Table 67: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Antifungal Susceptibility Testing Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	837,771,622.25 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Bio-Rad; Etest; ATCC; Ganesh Diagnostic; Ridacom; EWC Diagnostics; CLSI
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options